Vascular endothelial growth factor, interleukin 6 and leptin in the serum and vitreous fluid of type 2 diabetic patients

Journal of Medical Sciences (Peshawar)

Volumn 21, Issue 1, 2013, Pages 40-43

  Parveen, Nargis ^a   Zia Qureshi, Irfan ^b  

^a KHYBER TEACHING HOSPITAL   (Pakistan)

^b QUAID I AZAM UNIVERSITY   (Pakistan)

Author keywords

Diabetic retinopathy; Intereukin 6; Leptin; Type 2 diabetes mellitus; Vascular endothelial growth factor

Indexed keywords

CREATININE; GLUCOSE; HEMOGLOBIN A1C; INTERLEUKIN 6; LEPTIN; LIPID; UREA; VASCULOTROPIN;

ADULT; AGED; ARTICLE; BODY MASS; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIABETIC RETINOPATHY; DIASTOLIC BLOOD PRESSURE; DIET RESTRICTION; DISEASE COURSE; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PROLIFERATIVE RETINOPATHY; PROTEIN BLOOD LEVEL; SEX DIFFERENCE; SYSTOLIC BLOOD PRESSURE; VITREOUS BODY;

EID: 84879763292     PISSN: 19973438     EISSN: 19973446     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Shaw JE, Sicree RA, Zimmet PZ. Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Research and Clinical Practice 2010; 87: 4-14.
2. Girach A, Andersen LA. Diabetic macular edema: A clinical overview. International Journal Clinical Practice 2007; 61: 88-97.
3. Klein R, Klein BE, Moss SE. Epidemiology of proliferative diabetic retinopathy. Diabetes Care. 1992; 15: 1875-91.
4. Hammes HP. Pathophysiological mechanisms of diabetic angiopathy. Journal of Diabetes and Its Complications 2002; 17: Suppl 16-19.
5. Norbert D, Wangsa, Linsenmeier RA. Retinal Oxygen; Fundamental and clinical aspects. Arch Ophthalmol. 2003; 121: 547-57.
6. Viswanath K, McGavin M. Diabetic retinopathy: Clinical findings and management: Community Eye Health. 2003; 16: 21-24.
7. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent DM. N Engl J Med 1993; 329: 977-86.
8. Moan MC, Kadayifcilar S, Eldem B. Elevated intravitreal interleukin-6 levels in patients with proliferative diabetic retinopathy. Canadian journal of ophthalmology 2006; 41: 747-52.
9. Gonzalez RR, Cherfils S, Escobar M, Yoo JH, Carino C, Styer AK. Leptin signaling promotes the growth of mammary tumors and increases the expression of vascular endothelial growth factor and its receptor type two (VEGF-R2). J Biol Chem 2006; 281: 26320-28.
10. Aiello LP: Clinical implications of vascular growth factors in proliferative retinopathies. Curr Opin Ophthalmol 1997; 8: 19-31.
11. Lip PL, Belgore F, Blann AD, Hope-Ross MW, Gibson JM, Lip GY. Plasma VEGF and soluble VEGF receptor FLT-1 in proliferative retinopathy: relationship to endothelial dysfunction and laser treatment. Invest Ophthalmol Vis Sci. 2000; 41: 2115-19.
12. Mahdy RA, Nada WM. Evaluation of the role of vascular endothelial growth factor in diabetic retinopathy. Ophthalmic Res. 2011; 45: 87-91.
13. Brooks HL Jr, Caballero S Jr, Newell CK. Vitreous levels of vascular endothelial factor and stromal derived factor 1 in patients with diabetic retinopathy and cystoid macular edema before and after the intraocular injection of triamcinolone. Archive of ophthalmology 2004; 122: 1801-07.
14. Cohen T, Nahari D, Cerem LW, Neufeld G, Levi BZ. Interleukin 6 induces the expression of vascular endothelial growth factor. J Biol Chem. 1996; 271: 736-41.
15. Koleva-Georgieva DN, Sivkova NP, Terzieva D. Serum inflammatory cytokines IL-1beta, IL-6, TNF-alpha and VEGF have influence on the development of diabetic retinopathy. Folia Medica 2011; 53: 44-50.
16. Meleth AD, Agron E, Chan C, Reed GF, Arora K, Byrnes G, Csaky KG, Ferris FL, Chew EY. Serum Inflammatory Markers in Diabetic Retinopathy. Invest Ophthalmol Vis Sci. 2005; 46: 4295-301.
17. Uckaya G, Ozata M, Bayraktar Z, Erten V, Bingol N, Ozdemir IC. Is leptin associated with diabetic retinopathy? Diabetes Care 2000; 23(3): 371-76.
18. Jin X, Fukuda N, Su J, Takagi H, Lai Y, Lin Z, et al. Effects of leptin on endothelial function with OB-Rb gene transfer in Zucker fatty rats. Atherosclerosis 2003; 169: 225-33.
19. Sari R, Balci MK, Apaydin C. The relationship between plasma leptin levels and chronic complication in patients with type 2 diabetes mellitus. Metabolic Syndrome Related Disorders 2010; 8: 499-503.
20. Aamir AH, Rahman S, Ali SS, Jadoon MZ. Pattern of microvascular complications and associated comorbidities amongst diabetic patients at a tertiary care hospital. J Postgrad Med Inst 2005; 19: 400-06.
21. Arbab TM, Hanif S, Iqbal S, Mirza MA. Hypertension as risk factor in diabetic retinopathy in type-2 diabetes. Pak J Ophthalmol 2008; 24: 201-03.
22. Hosseini SM, Maracy MR, Amini M, Baradaran HR. A risk score development for diabetic retinopathy screening in Isfahan-Iran. Journal of Research in Medical Sciences 2009; 14: 105-110.
23. Gillow JT, Gibson JM, Dodson PM. Hypertension and diabetic retinopathy, what's the story? Br J Ophthalmol 1999; 83: 1083-87.